T2 Biosystems, Inc.
OTC: TTOO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Craig R. Jalbert
- Employees
- 113
- Headquarters
- Lexington, United States
- IPO year
- 2014
- Market cap
- $84.1K
- Website
- https://www.t2biosystems.com
Loading TTOO…
Loading profile data…Frequently asked questions about TTOO
What does T2 Biosystems, Inc. (TTOO) do?
T2 Biosystems, Inc. is an in vitro diagnostics company that develops and commercializes innovative diagnostic solutions for global markets. Its proprietary technology platform enables the rapid detection of pathogens, biomarkers, and other critical abnormalities directly from a wide array of unpurified patient specimens, including whole blood, p...
Where does TTOO trade?
T2 Biosystems, Inc. (TTOO) trades on the Other OTC.
What sector is TTOO in?
T2 Biosystems, Inc. (TTOO) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of T2 Biosystems, Inc.?
Craig R. Jalbert is the chief executive officer of T2 Biosystems, Inc. (TTOO).
Where is T2 Biosystems, Inc. headquartered?
T2 Biosystems, Inc. is headquartered in United States.
Does TTOO pay a dividend?
T2 Biosystems, Inc. (TTOO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TTOO go public?
T2 Biosystems, Inc. (TTOO) completed its initial public offering in 2014.